// App-Quantinova.ai

4723 : Innovative cancer treatment of human lung cancer cells PC-9 with a synthetic retinoid Am80 and EGCG via inhibition of HDAC4 and HDAC5

Researchers

Presenter

  • Masami Suganuma

Principal Investigators

  • Yukiko Oya

  • Sonthaya Umsumarng

  • Keisuke Iida

  • Anchalee Rawangkhan

  • Ryo Sakai

  • Hiroyuki Kagechika

  • Koichi Shudo

  • Hirota Fujiki

Medical Centers

  • Saitama Medical University, Saitama, Japan

  • Tokyo Medical and Dental University, Tokyo, Japan

  • Japan Pharmaceutical Information Center, Tokyo, Japan

  • Kanazawa University, Kanazawa, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute promyelocytic leukemia

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • p53

  • Histone deacetylase 4

  • Epigallocatechin gallate

Drug/Treatment

  • Tretinoin

  • Tamibarotene

  • Celecoxib

  • ALT-210

  • Sulindac

  • Tigason

  • EGCG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved